Anjali Singh, Business Standard

Stories by Anjali Singh, Business Standard

'You End Up Firefighting': Finance Minister

'You End Up Firefighting': Finance Minister

Rediff.com   22 hours ago

'Uncertainty level A in the morning, uncertainty level B in the afternoon. If I answer about tariff rates now, I'll be outdated by the evening.'

'India Is A Reverse AI Trade Globally'

'India Is A Reverse AI Trade Globally'

Rediff.com   1 days ago

'The day that the market realises that they've overspent (on AI) and there's a sudden collapse in the capex, then India can start outperforming again.'

AI Can Make India World's Creative Capital

AI Can Make India World's Creative Capital

Rediff.com   5 days ago

'Not the back office for the world's content. The leader. The standard-setter.'

Hyderabad claims its place as global MNC destination

Hyderabad claims its place as global MNC destination

Rediff.com   18 Feb 2026

Hyderabad is rapidly emerging as a strategic hub for multinational companies (MNCs) deepening their focus on artificial intelligence (AI), life sciences, and global capability centres (GCCs), supported by the city's strong pharmaceutical (pharma) base, deeptech talent pool, and a policy environment that encourages high-value investment.

Electric vehicle retail sales zoom in Jan

Electric vehicle retail sales zoom in Jan

Rediff.com   12 Feb 2026

India's electric vehicle (EV) markets expanded gains in January compared to the year-ago period, as two-wheeler and passenger vehicle sales triggered a shuffle in the competitive landscape, data from an automobile dealers' association showed.

Rare-Disease, Cancer Drugs Get Cheaper

Rare-Disease, Cancer Drugs Get Cheaper

Rediff.com   3 Feb 2026

For patients, the immediate impact is a reduction in the final cost of therapies that often run into lakhs per month.

Bajaj Auto logs best quarterly earnings in Q3

Bajaj Auto logs best quarterly earnings in Q3

Rediff.com   31 Jan 2026

Two-wheeler (2W) major Bajaj Auto on Friday posted its highest ever quarterly revenue and profit during the third quarter of 2025-26 (Q3FY26). Bajaj Auto's consolidated net profit for the quarter grew by 25 per cent year-on-year (Y-o-Y) to Rs 2,749 crore, with the revenue also growing 23 per cent to Rs 16,204 crore.

E2W companies seek PM E-Drive subsidy extension beyond March 2026

E2W companies seek PM E-Drive subsidy extension beyond March 2026

Rediff.com   27 Jan 2026

India's electric two-wheeler (e2W) manufacturers have urged the government to extend subsidies under the PM E-Drive (Electric Drive Revolution in Innovative Vehicle Enhancement) scheme beyond March 2026, cautioning that a withdrawal could slow near-term demand even as confidence in long-term electric mobility adoption remains intact.

Southern states hold the steering wheel in India's ePV transition

Southern states hold the steering wheel in India's ePV transition

Rediff.com   20 Jan 2026

India's electric passenger vehicle (ePV) market has expanded sharply over the past five years, with registrations rising from just 3,252 units in 2020 to about 170,000 in 2025. Throughout this scale-up, southern states have remained the bedrock of adoption, consistently contributing around one-third of national electric vehicle (EV) registrations - emphasising the region's role as the structural backbone of India's EV transition.

Two-wheeler Industry hits speed bump over ABS mandate

Two-wheeler Industry hits speed bump over ABS mandate

Rediff.com   19 Jan 2026

India's two-wheeler industry is seen growing 6-9% in 2026, though a proposed ABS mandate for sub-125cc models could push up prices and temper volumes.

SUVs rule resale market despite small cars getting cheaper

SUVs rule resale market despite small cars getting cheaper

Rediff.com   13 Jan 2026

Data from used-car platforms suggest that buyer preferences have remained broadly stable post-GST, with SUVs retaining their dominance even as price adjustments played out across segments.

Carmakers Go Deep In Bid To Expand Beyond Metros

Carmakers Go Deep In Bid To Expand Beyond Metros

Rediff.com   12 Jan 2026

Network scale seen as central to tapping smaller markets.

Indian pharma companies see sharp drop in adverse USFDA findings in 2025

Indian pharma companies see sharp drop in adverse USFDA findings in 2025

Rediff.com   8 Jan 2026

The US Food and Drug Administration (USFDA) recorded a significant decline in serious regulatory findings at Indian drug manufacturing facilities between January and December 2025. Data reveals that 'official action indicated' (OAI) cases - the most severe classification - nearly halved over the past year.

Northern Borders 'Stable Yet Sensitive': Defence Ministry

Northern Borders 'Stable Yet Sensitive': Defence Ministry

Rediff.com   3 Jan 2026

The deployment of the army in all sectors along the Line of Actual Control, the de facto border between India and China, is 'robust, well poised and prepared to deal with any emerging contingency'.

3.84 Trillion Spent On These Weapons...

3.84 Trillion Spent On These Weapons...

Rediff.com   2 Jan 2026

The largest tranche came in July, in the wake of Operation Sindoor, with the DAC according acceptance of necessity -- or initial approval -- for 10 capital acquisition proposals amounting to approximately 1.05 trillion through indigenous sourcing.

India's diagnostic chains are in expansion mode. Here's why

India's diagnostic chains are in expansion mode. Here's why

Rediff.com   29 Dec 2025

India's diagnostics sector is accelerating capacity addition and geographic expansion, as large chains and regional players invest in new laboratories, integrated centres and dense sample collection networks to tap rising demand for preventive, advanced and precision testing.

Carmakers Gear Up To Hit Refresh Button

Carmakers Gear Up To Hit Refresh Button

Rediff.com   27 Dec 2025

'In India's competitive automotive market, staying relevant means continuously raising the bar.'

Cancer Therapies Break New Ground

Cancer Therapies Break New Ground

Rediff.com   26 Dec 2025

'India is clearly moving toward more targeted treatment pathways in high-burden cancers.'

Emcure sets sights on pan-Indian obesity market with Poviztra

Emcure sets sights on pan-Indian obesity market with Poviztra

Rediff.com   23 Dec 2025

Emcure Pharmaceuticals on Monday said it saw Poviztra, its newly launched semaglutide brand, as a "long-term" opportunity in India's fast-evolving obesity and cardiometabolic therapy market, even as price competition in the glucagon-like peptide-1 (GLP-1) segment intensified.

SIM-Binding Standoff: Telcos Vs Apps

SIM-Binding Standoff: Telcos Vs Apps

Rediff.com   17 Dec 2025

App-based communication services providers and Indian telcos are at loggerheads over the SIM-binding directions issued by the department of telecom, which are to be complied with by the end of February 2026.